KR100346619B1 - 8-사이클로펜틸-6-에틸-3-[치환된]-5,8-디하이드로-4에이치-1,2,3에이,7,8-펜타아자-비대칭-인다센의 제조 방법 및이 방법에 유용한 중간체 - Google Patents

8-사이클로펜틸-6-에틸-3-[치환된]-5,8-디하이드로-4에이치-1,2,3에이,7,8-펜타아자-비대칭-인다센의 제조 방법 및이 방법에 유용한 중간체 Download PDF

Info

Publication number
KR100346619B1
KR100346619B1 KR1020000023025A KR20000023025A KR100346619B1 KR 100346619 B1 KR100346619 B1 KR 100346619B1 KR 1020000023025 A KR1020000023025 A KR 1020000023025A KR 20000023025 A KR20000023025 A KR 20000023025A KR 100346619 B1 KR100346619 B1 KR 100346619B1
Authority
KR
South Korea
Prior art keywords
formula
compound
reaction mixture
methoxybenzyl
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020000023025A
Other languages
English (en)
Korean (ko)
Other versions
KR20010029673A (ko
Inventor
어반프랭크존
Original Assignee
화이자 프로덕츠 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 화이자 프로덕츠 인코포레이티드 filed Critical 화이자 프로덕츠 인코포레이티드
Publication of KR20010029673A publication Critical patent/KR20010029673A/ko
Application granted granted Critical
Publication of KR100346619B1 publication Critical patent/KR100346619B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020000023025A 1999-04-30 2000-04-29 8-사이클로펜틸-6-에틸-3-[치환된]-5,8-디하이드로-4에이치-1,2,3에이,7,8-펜타아자-비대칭-인다센의 제조 방법 및이 방법에 유용한 중간체 Expired - Fee Related KR100346619B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13194999P 1999-04-30 1999-04-30
US60/131,949 1999-04-30

Publications (2)

Publication Number Publication Date
KR20010029673A KR20010029673A (ko) 2001-04-06
KR100346619B1 true KR100346619B1 (ko) 2002-07-26

Family

ID=22451736

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020000023025A Expired - Fee Related KR100346619B1 (ko) 1999-04-30 2000-04-29 8-사이클로펜틸-6-에틸-3-[치환된]-5,8-디하이드로-4에이치-1,2,3에이,7,8-펜타아자-비대칭-인다센의 제조 방법 및이 방법에 유용한 중간체

Country Status (24)

Country Link
US (1) US6326495B2 (enExample)
EP (1) EP1048667B1 (enExample)
JP (1) JP3510560B2 (enExample)
KR (1) KR100346619B1 (enExample)
CN (2) CN1160353C (enExample)
AR (1) AR029450A1 (enExample)
AT (2) ATE282039T1 (enExample)
AU (1) AU761391B2 (enExample)
BR (1) BR0002070A (enExample)
CA (1) CA2307080C (enExample)
DE (2) DE60015819T2 (enExample)
DK (2) DK1048667T3 (enExample)
ES (2) ES2207464T3 (enExample)
HU (1) HUP0001700A3 (enExample)
ID (1) ID25705A (enExample)
IL (1) IL135809A0 (enExample)
IN (1) IN192746B (enExample)
MX (1) MXPA00004214A (enExample)
PL (1) PL339985A1 (enExample)
PT (2) PT1380585E (enExample)
RU (1) RU2189985C2 (enExample)
TR (1) TR200001161A2 (enExample)
TW (1) TWI256392B (enExample)
ZA (1) ZA200002057B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8541333B2 (en) 2009-08-13 2013-09-24 China Petroleum & Chemical Corporation Catalyst component for olefin polymerization and a catalyst comprising the same
EP3045450B1 (en) 2010-09-08 2018-02-07 Sumitomo Chemical Co., Ltd. Intermediate compounds in processes for producing pyridazinone compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1094303A1 (ru) * 1982-12-24 1987-12-30 Институт физико-органической химии и углехимии АН УССР 3-Трифторметил-7-метилимидазо- @ 4,5-с @ -1,2,4-триазоло @ 4,3-а @ пиридин,обладающий спазмолитическим действием
US4940715A (en) * 1988-05-17 1990-07-10 Kissei Pharmaceutical Co., Ltd. 5H-pyrazolo[4,3-A] quinolizin-5-one compounds exhibiting therapeutic activities
CA2166721C (en) 1993-07-06 1999-07-27 Allen Jacob Duplantier Bicyclic tetrahydro pyrazolopyridines
JPH09511758A (ja) 1994-10-20 1997-11-25 フアイザー・インコーポレイテツド 二環式テトラヒドロピラゾロピリジンおよび医薬としてのその使用
SK282167B6 (sk) 1995-06-06 2001-11-06 Pfizer Inc. Tricyklické 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-a] pyridíny a farmaceutický prostriedok na ich báze

Also Published As

Publication number Publication date
ID25705A (id) 2000-11-02
AU761391B2 (en) 2003-06-05
CA2307080A1 (en) 2000-10-30
IN192746B (enExample) 2004-05-15
DK1048667T3 (da) 2004-03-01
RU2189985C2 (ru) 2002-09-27
HK1031881A1 (en) 2001-06-29
EP1048667B1 (en) 2003-10-22
PT1048667E (pt) 2004-03-31
US6326495B2 (en) 2001-12-04
TR200001161A2 (tr) 2000-12-21
ZA200002057B (en) 2001-10-26
HU0001700D0 (en) 2000-07-28
ATE282039T1 (de) 2004-11-15
MXPA00004214A (es) 2002-03-08
US20010039347A1 (en) 2001-11-08
HK1062678A1 (en) 2004-11-19
ES2232805T3 (es) 2005-06-01
KR20010029673A (ko) 2001-04-06
ATE252582T1 (de) 2003-11-15
PL339985A1 (en) 2000-11-06
TWI256392B (en) 2006-06-11
CN1478779A (zh) 2004-03-03
EP1048667A1 (en) 2000-11-02
DE60006026D1 (de) 2003-11-27
HUP0001700A2 (en) 2001-03-28
CN1160353C (zh) 2004-08-04
CN1249064C (zh) 2006-04-05
PT1380585E (pt) 2005-03-31
CN1274724A (zh) 2000-11-29
BR0002070A (pt) 2000-10-31
JP2000344771A (ja) 2000-12-12
CA2307080C (en) 2003-12-23
JP3510560B2 (ja) 2004-03-29
DK1380585T3 (da) 2005-03-07
HUP0001700A3 (en) 2001-05-28
AR029450A1 (es) 2003-07-02
IL135809A0 (en) 2001-05-20
AU3018000A (en) 2000-11-02
DE60006026T2 (de) 2004-06-17
DE60015819D1 (de) 2004-12-16
ES2207464T3 (es) 2004-06-01
DE60015819T2 (de) 2005-12-08

Similar Documents

Publication Publication Date Title
US20040138459A1 (en) Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via 1H-imidazo [4,5-C] quinolin-4-phthalimide intermediates
JPH1072445A (ja) 置換インダゾール誘導体
WO2008087557A2 (en) An improved process for preparation of 9-hydroxy-3-(2-chloroethyl)- 2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one hydrochloride
EP2571857B1 (en) Process for the preparation of pyrimidinone compounds
KR100346619B1 (ko) 8-사이클로펜틸-6-에틸-3-[치환된]-5,8-디하이드로-4에이치-1,2,3에이,7,8-펜타아자-비대칭-인다센의 제조 방법 및이 방법에 유용한 중간체
JP4208463B2 (ja) キノロンカルボン酸誘導体の製造に関する中間体
EP2489666A2 (en) Chemically and chirally pure solifenacin base and its salts
CN108727224B (zh) 药物合成用中间体的制备方法
EP1380585B1 (en) Pyrazolopyridinone as intermediate
EP3971186B1 (en) Preparation method for indole or indazole compound
EP1831219A2 (en) A process for the preparation of substantially pure 4-amino-1-isobutyl-1h-imidazoý4,5-c¨-quinoline (imiquimod)
KR102389716B1 (ko) 인돌 또는 인다졸 화합물의 제조방법
AU2003212585B2 (en) Methods of preparation of the 2-(7-chloro-1,8-naphthyridine-2YL)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone
CZ20001569A3 (cs) Způsob a meziprodukty pro výrobu 8- cyklopentyl-6-ethyl-3-[substituovaných]-5,8- dihydro-4H-l,2,3a,7,8-pentaaza-as-indacenů
JPH0412272B2 (enExample)
WO2008053324A1 (en) An improved process for the preparation of gemifloxacin mesylate
CN101193865A (zh) 3-氨基-4-取代吡唑衍生物的合成
NZ626732B2 (en) Process for the preparation of (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid esters
HK1074439A1 (en) Quinoline derivatives and their use as 5-ht6 ligands

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20060630

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20070717

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20070717